Takeda Pharmaceutical Co Ltd (NYSE:TAK)

16.51
Delayed Data
As of Aug 21
 -0.26 / -1.55%
Today’s Change
15.50
Today|||52-Week Range
21.95
-1.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

2019
Revenue and IncomeNet Revenues15.1B16.0B16.0B18.9B
 
 
 
 
 
Cost of Goods Sold3.9B4.6B4.0B5.2B
 
 
 
 
 
Depreciation And Amortization1.5B1.6B1.6B2.5B
 
 
 
 
 
 
Operating ExpensesGross Income9.7B9.8B10.4B11.2B
 
 
 
 
 
General Expenses8.3B8.6B8.6B9.6B
 
 
 
 
 
Other Operating Expenses-53.2M--0.000.00
 
 
Research And Development2.9B2.9B2.9B3.3B
 
 
 
 
 
Total Operating Expenses13.6B14.8B14.2B17.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.5B1.2B1.8B1.6B
 
 
 
 
 
Extraordinary Credit118.2M170.3M35.9M53.8M
 
 
 
 
 
Extraordinary Charge-492.8M-1.1B-1.1B-1.2B
 
 
 
 
 
Pre-Tax Equity Earnings-25.0K-14.3M-290.5M-393.4M
 
 
 
 
 
Interest Expense On Debt66.3M69.8M114.9M614.8M
 
 
 
 
 
Other Expenses-38.4M1.1B1.6B1.3B
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.0B1.3B2.0B855.7M
 
 
 
 
 
Income Taxes-308.7M-257.0M-275.2M-127.3M
 
 
 
 
 
Minority Interest-27.6M-5.3M-1.6M-1.0M
 
 
 
 
 
Net Income667.8M1.1B1.7B984.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6B1.6B1.6B1.9B
 
 
 
 
 
Shares To Calculate EPS Diluted1.6B1.6B1.6B1.9B
 
 
 
 
 
 
Earnings Per ShareEPS$0.43$0.68$1.08$0.51
 
 
 
 
 
EPS Diluted$0.42$0.68$1.07$0.51